TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Evaxion Biotech A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
765
|
0
![]() |
0 |
Earnings before taxes |
-238,169
|
-240,348
|
-215,147 |
Total assets |
139,457
|
212,950
|
352,749 |
Current assets |
84,604
|
156,685
|
298,560 |
Current liabilities |
80,393
|
32,705
|
37,364 |
Equity capital |
-48,102
|
81,943
|
285,430 |
- share capital |
57,158
|
34,170
|
31,121 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-34.5%
|
38.5%
|
80.9% |
Turnover per employee |
22
|
0
![]() |
0 |
Profit as a percentage of turnover | -31133.2% | ||
Return on assets (ROA) | |||
Current ratio |
105.2%
|
479.1%
|
799.1% |
Return on equity (ROE) |
495.1%
|
-293.3%
|
-75.4% |
Change turnover |
765
|
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.